A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

Beijing Friendship Hospital (Other)
Overall Status
CT.gov ID

Study Details

Study Description

Brief Summary

A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object. Preoperative and postoperative demographic data, ultrasonography, other relevant laboratory tests, and thyroid disease-related scales such as fatigue, depression, and stress were collected. The influencing factors of PTC recurrence were analyzed.

Condition or Disease Intervention/Treatment Phase
  • Other: No Intervention

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
600 participants
Observational Model:
Time Perspective:
Official Title:
A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Feb 28, 2028
Anticipated Study Completion Date :
Feb 28, 2028

Arms and Interventions

Arm Intervention/Treatment
No Intervention

Other: No Intervention
No Intervention

Outcome Measures

Primary Outcome Measures

  1. the recurrence of PTC [1 to 5 years]

    the recurrence of PTC during follow-up

Eligibility Criteria


Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Inclusion Criteria:

①≥18 years old; ② Obtain informed consent; ③ Ultrasonography showed that malignant nodules were single, the maximum diameter of nodules was ≤1cm and the distance from the capsule was ≥2mm. ④ no lymph node metastasis or other extra-glandular metastasis in the neck; ⑤ PTC was confirmed by fine needle puncture pathology; ⑥ Patients who do not meet Article 3, who still strongly request thermal ablation while fully informing the patient of the risk of recurrence, and who have been clinically assessed to be technically capable of thermal ablation Exclusion Criteria:① Pregnant or lactating patients; ② Patients with other malignant tumors and not suitable for ablation by clinical evaluation; ③ Patients who cannot tolerate surgery; ④ Patients with cognitive impairment and other conditions who cannot accurately fill in thyroid-related questionnaires.

Contacts and Locations


Site City State Country Postal Code
1 Beijing Friendship Hospital Beijing China

Sponsors and Collaborators

  • Beijing Friendship Hospital


None specified.

Study Documents (Full-Text)

None provided.

More Information


None provided.
Responsible Party:
Beijing Friendship Hospital
ClinicalTrials.gov Identifier:
Other Study ID Numbers:
  • MR-11-23-009728
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:
Studies a U.S. FDA-regulated Drug Product:
Studies a U.S. FDA-regulated Device Product:
Keywords provided by Beijing Friendship Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023